Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

specific immunity
Mo.A.523, Mo.B. 1 335, Th.A.40 18,
We.A.380, We.A.394, We.B.3373
specificity of antibodies
Mo.B. 1177
spermicides, SEE microbicides
Mo.D.583, Th.C.322, Th.C.322, Th.C.430,
Th.C.4495, We.A.5 10, We.A.5 13
spiramycin
PLI.C.I1101
spleen
Th.B.4287, We.A.3003, We.B. 112,
We.B.3349, We.C.345 I
stages, SEE progression
Mo.B. 17,327,Th.A. I160, Th.A.4075,
We.B.3334, We.B.3339
standardisation
Th.A.4022, Vh.B.4339, We.B.3 158,
We.C.3444
staphylococcus aureus
Th.B.4189,Tu.A.21 I I,We.B.3205,
We.B.3206
statistical methods
MoC. 140 1, Mo.C 1426, Mo.C. 1558,
Mo.C. 1582, MoC. 1594, Mo.C.573,
Th.C. I120, Th.C. I125, Tu. B. 11I2. Tu.B.2 34 I,
Tu.B.2375,Tu.B.522, Tu.C.573, We.B.3249,
We.C.2 10
stavudine
Mo.A. 1012, Mo.A. 1078, Mo.A.I I IS5,
Mo.B. 1122, Mo.B. I1194, Mo.B. 1376,
Th.B.293,Th.B.4244,Tu.B.2 I1I5, Tu.B.2 130,
Tu.B.2 I 32,Tu.B.2 134
STD clinics
Mo.C. 1412, MoC. 14 I13, Mo.C. 1414,
MoC.1421, MoC. 1431, MoC. 1475,
Mo.C. 1488, Ma.C. 1526, Mo.C. 1553,
Mo.C. 1567, MoC. 161 1, Ma.C. 1619,
MoC. 1625, MoC. 1635, Mo.C.2 14,
Mo.C.44 I, MoD. 1752, Mo.D. 1753,
Pub.B. 1042, Pub.B. 1049, Pub.C. I1244,
Pub.C. I1280, Pub.D. I1358, Pub.D. I1459,
Th.C.202, Th.C.4382, TL.C.4425,
Th.C.4626,Th.C.4732,Th.C.4734,
Th.C.4736,Th.C.4738,Th.C.4744,
Th.C.4754, Th.C.4756, Vh.C.4778,
Th.D.5052, Tu.A.374, Tiu.B.22 30,
Tu.C.2409,Tu.C.243 I,TuC.2458,
Tu.D.29 I12, We.C.3509, We.C.3525,
We.C.3527
STDs (sexually transmitted diseases)
MoB.1209, Mo.B.54 1, Mo.C.1413,
MoC.1432, Mo.C. 1435, Mo.C. 1436,
Ma.C. 1441, Ma.C. 1474, Ma.C. 1477,
Ma.C. 1478, Ma.C. 1484, Ma.C. IS516,
Mo.C.1553, Mo.C.161 I, Mo.C. 1612,
Mo.C. 1613, Mo.C.16 IS, Mo.C. 1616,
Mo.C.16 17, Mo.C. 16 18, Mo.C.1619,
Mo.C. 1620, Ma.C. 1621, Mo.C. 1623,
Mo.C. 1625, Mo.C. 1626, Ma.C. 1627,
Mo.C. 1628, Ma.C. 1629, Ma.C. 1631,
Ma.C. 1632, Mo.C. 1633, Ma.C. 1635,
Mo.C. 1666, Mo.C.2 14, Mo.C.222,
Mo.C.340, Mo.C.342, Mo.C.343,
Mo.C.344, Mo.C.345, Mo.C.440,
Mo.C.44 I, Mo.C.443, Mo.C.444,
MoD.1696, MoD. 173 I, Mo.D. 1746,

Th.C.4744,Th.C.4745, Ih.C.4747,
Th.C.4748, Th.C.4749, Th.C.4 750,

Th.C.4752, Th.C.4753 Tb (.47/56,
Th.C.4778, Th.C.4827, Th.(.4835,
Th.D.440,3 S D.S0t) 3 h [3 047,T u.B. 184,
Tu.B.2 145,Tu.B.2h 30,Tiu.C.2 10,
Tu.C.2396, Tu.C.2409, IL (2 418,
Tu.C.2476, Tu.C.2484 Tu.C2508,
Tu.C.25 II,3u.C.25 38,Tv 2544,
Tu.C.26 17TuC26I9 1C2620,
Tu.C.2623 Eu.C 2634 TLJC 2657,
Tu.C.266 I Tu.C. v66, ii C.2668,
Tu.C.2686,Tu.C.268 9:,Tu.C.2692,
Tu.C.563,Tu.[3.242, 1.13.2/101I, Tu.D.27 IS,
Tu.D.28 I12, We.A.5 i3, We 0.3 185,
We.B.3 I188, We.8.3 I189. We.B.3 I19 I,
We.B.3 192, We.B.545, We.C, 23,
We.C.222, We.C.3402, We.C,3405,
We.C.3450, We.C.3596, We.D.3706,
We.D.3742
stem cells
Mo.A. I1046, We.A.272, We.83 183
Steven Johnson's syndrome
Mo.B. I202,Tu.B.2 I I9
stigma
Mo.D.134, Pub.C. I2 I 5. Pub.C. I1222,
PLJ.D. 133 I, Pub.D. I1343, Pub.D.1I474,
Th.C.463 I,Th.D.253,Th.D.4864,
Th.D.5069, Th.D.5083,Th.D.5 107,
Tu.D.2857,Tu.D.29 I16, We.B.3 I141,
We.D.3628, We.D.3 09
stomatitis, angular
We.C.3554
strain, variation
Mo.A. 160, Mo.A.390, Pub.A. 1019,
Th.A. I144,Th.B.4347,Tu.A.2052,Tu.A.373,
Tu.B.2 I 98,Tu.B.224 2, Tj.C.220, Ti.C.2426
strains, virulence
Mo.A.390,Tu.A.2065, 13(7.26,
We.C.3393
street involved youth
Ma.C. 1609, Ma.D.580, Pub,C. I1146,
Th.C.4362, Th.C.4633,Th.C.4675,
Th.C.468 I,Th.C.47 42, Th.D.444,
Th. D.4904, Th. D.4906, Th.D.491I2,
T h. D.49 I14, Th. D. 49 I17, T h. D.49 I18,
Th.D.492 I,Th.D.4923,Th.D.4924,
Th.D.493 I,Th.D.4933,Th.13.S(40,
Tu.C.2629, We.C.206. We.[3.480
street-based outreach programs
Mo.D.1744, Mo.D.245, Pub.C.1I252,
Pub.D. 1303, Pub.D. I 356,Th.C.4633,
Th.C.464 I,Th.C.4643, 1I.C.4647,
Th.C.4662,Th.C.46/0 [11.0.468 I,
Th.D.4907, Th.D.492 I,Th.D,4933,
Tu.D.2833, We.C.206, We.C31484,
We.C.3544, We.C.3552, We.C.3563,
We.D.3665, We.D.480
streptococcus pneumoniae
Tu.B.2 177, We.C.3423
stress
Ma.D. I1849, MaD. I1861, PaC.D. I1478,
Pub.D. I 487, Th.B.4 02, Th.B.4 105,
Th.C.4608,Th.D.5089,TI D.5 I02,
-Tu.A.2032, We.A.307 3, We1.D.250,
We.D.364 I, We.D.370, W~e.D.37 16,
We.D.373, We.Df.. 3,4, 7/c.38 12,
We.D.3868, We.D.3870, We.[3.3873,
We.D.3874

subgroups
Ma.A. 1005, Ma.C. 1438, Mo.C. 1480,
Pub.C. I I49, Pub.D. 1473, Pub.D. I1492,
Tu.A.2062, Tu.A.372, Tu. B.3 I12, Tu.C.2652,
Tu.D.2765, We.C.34 I
substance use (non-injecting)
Mo.B. 1390, MoD. 1726, Mo.D. 1754,
Mo.D. 1941I, Pub.C. I1I82, Pub.C. I1255,
Th.C.4705, Th.D.S I I2,Th.[).5 I193,
Tu.C.24 14, We.C.3490
substrate
Th.C.4362
suicide
Ma.C. 1541, Ma.C. 1543, Ma.C. 1545,
Mo.D. I1825, Mo.D.48 I,Th.D.509 I,
1 h.D.5 I165, We.B.33 10, We.D.240,
VWe.D.24 I, We.D.242, We.D.243,
We.D.244, We.D.246
sulfated polysaccharides
Tu.B.2280
sulfolipids
Mo.D.19 14
sulfonamide
Mo.B. I1I93,blo.B. I 204,Tu.B.229 I,
Tu.B.4 I13
sulphated compounds
Th.B.4 1 06, We.B.3 129
superantigen
Th.A. 14S, We.A.3058
support groups
Mo.B. I1167, Ma.D. 1764, Ma.D.230,
Pub.C. I1I25, Puh.C. I1I48, Pub.C. I1225,
Pub.D. 1476, Pub.D. I1478, Pub.D. 1482,
Pub.D. I 492,Th.C.45 I 3,Th.C.4584,
Th.C.4647, T.C.4844, Th.D.25 3,
Th.D.4923, Th.D.5 I I2,Th.D.5 I1I6,
T6.13.5 133, Th.[3.5 I 34,Th.D.5 135,
Th.D.5 I 36,Th.D.5 I 38,Th.D.5 142,
Th. D.5 I16 I, Th.[D.5 I 97, Tu. B. 2136,
Tu.C.235,Tu D.236,Tu.D.2920,Tu.D.2926,
Tu.D.2953,Tu.D.363, We.D.36 I I,
We.D.3686, We.D.3692, We.D.3698,
We.D.3738, We.D.3762, We.D.3836,
We.D.3864, We.D.3867, We.D.39 I12,
We.D.472, We.D.603
surgeons, SEE health care personnel
Th.B.4292
surgery
Ma.B. I1I3, bla.B. I1208, Mo.B. 1262,
Pub. B. 1071, lh.B.'1290,Th.B.429 I,
Tb.B.4292, We.B.3300
surrogate markers, SEE markers,
surrogate
Mo.B. I1129, Mo.B. 13S2, Mo.B.295,
Mo.D. 1768, Pub.B. 1084, Pub.B. 1085,
Pub.B. I 089, Th.B.4293, Th.B.4298,
Tu.B.2 I 26,Tu.B.2345,Tu.B.2347,
Tu.B.2370, We.A.303 I, We.B.3 136,
We.B.32 I12, We.B.3347, We.B.3349
surveillance
Ma.C. 1402, Ma.C. 1404, Ma.C. 1407,
Ma.C.14 I I, Ma.C. 1427, Ma.C. 1429,
Ma.C. 1434, Ma.C. 1437, Ma.C. 1439,
Ma.C. 1454, Ma.C. 1457, Ma.C. 1464,
MaC. 1465, Ma.C,1467, Ma.C. 1471,
Ma.C. 148 I, Ma.C,1496, Ma.C. 1500,
Ma.C. 1553, Ma.C. 1554, Ma.C. 155,

Pub.C..I1285, Pub.C. I289, Th.B.4 I66,
Th.C. I124,-TI,.C.203,T.C.330,Th.C.340,

Th.C.344,Th.C.4363, Th.C.4367,
Th.C.438 I,Th.C.4384,Th.C.47 I2,
Th.C.4746,Th.C.4749,Th.C.4767,
Th.C.4769,Th.C.4792,Tu.B.2 I58,
Tu.C.121, Tu.C.200,Tu.C.2402,Tu.C.2449,
Tu.C.2494,Tu.C.25 I 0,Tu.C.25 I18,
Tu.C.2528,Tu.C.253 I,Tu.C.2546,
Tu.C.2550,Tu.C.255 I,Tu.C.2559,
Tu.C.2560,Tu.C.2593,Tu.C.26 I19,
Tu.C.262 I,Tu.C.2627,Tu.C.2630,
Tu.C.2632,Tu.C.2652,Tu.C.56 I,
Tv.D.2906, We.B.303, We.B.3244,
We.B.420, We.C.3434, We.C.3453,
We.C.3475
survey, attitudes and knowledge
Mo.B. I1I36, Mo.B. I1168, Mo.B. 1205,
Mo.B. I1314, Mo.B. I183, Mo.B. 193,
Ma.C.1410, Mo.C. 1444, MoCISI I,
Ma.C. 1588, Mo.C.344, Mo.D. 133,
Ma.D. 134, Ma.D,1686, Mo.D. 1700,
Mo.D.1736, Mo.D. 1766, Ma.D. 1772,
Mo.D.1787, MoD lB19, Mo.D, 1821,
Mo.D,1826, Ma.D. 1834, Mo.D. 1839,
Ma.D. 1850, Mo.D. 1856, Mo.D. 1907,
Mo.D.1930, Pvb.C.I1121, Pub.C.I1146,
Pvb.C.I1149, Pvb.C.123 1, Pub.C.128 1,
Pvb.C.1283, PubD.1357, Pub.D.1359,
Pub.D. I1368, Pub.D. I1371, Pvb.D. 1406,
Pub.D. I 465,Th.C.4394,Th.C.4397,
Th.C.4440, Th.C.4522,Th.C.4526,
Th.C.4528,Th.C.4530,Th.C.453 I,
Th.C.4548,Th.C.4549,Th.C.458 I,
ThC.4598,Th.C.460 I,Th.C.4604,
Th.C.47 I16, Th.C.47 I17, Th.C.4728,
Th.C.4768, Th.C.4779, Th. D.4905,
Th. D.49 I17, Th. D.49 I18, Th. D.492.2,
Th.D.4925,Th.D.498 I,Th.D.5068,
Th.D.5 I 23,Th.D.5 I 26,Th.D.S I179,
Th.D.5 I 82,Th.D.5 I 83,Th.D.5 I184,
Th.D.5 I 85,T6.D.5 I 88,Tu.B. I175,
Tu.B.2 I 37,Tu.B.2 I1S I,Tu.C.25 I13,
Tu.C.2545,Tu.C.2594,Tu.C.2626,
Tu.C.2634,Tu.D.270 I,Tu.D.2702,
Tu.D.2705,Tu.D.27 I 0,TuD.27 I 1,
Tu. D.2742, Tu. D.2754, Tu. D.2780,
Tu.D.279 I,Tu.D.2796,Tu.D.2799,
Tu.D.2856,Tu.D.286 I,Tu.D.2957,
We.B.3 I12, We.B.3 143, We.B.3 I5 2,
We.B.3 I155, We.C.3486, We.C.3504,
We.D.243, We.D.244, We.D.3607,
We.D.36 I, We.D.3630, We.D.3639,
We.D.3784, We.D.482, We.D.483
survey, methodology
Ma.C. 1517, Ma.C. 1526, Ma.C. 1553,
Ma.C. 1638, Mo.D. 1685, Mo.D. 1703,
Mo.D.1716, Mo.D. 1853, Mo.D. 1854,
Mo.D. I1860, Mo.D. 1869, Pub.C. I1229,
Pub.D. I 465,Th.C.2 I 5,Th.C.4366,
Th.C.4396,Th.C.4679,Th.D.360,
Th.D.365,Th.D.5022,Tu.C.2545,Tu.D.470,
Tu.D.472,Tu.D.600, We.D.3807,
We.D.3884
survival
Mo.B. I1I35, Mo.B. 1228, MoB. 13 16,
Mo.B.1330, Mo.B. 1339, Mo.B. 1357,
Mo.B.433, Ma.C. 1459, Ma.C. 1555,
Mo.C.322, Mo.C.325, Mo.D. 1721,

We.C.3434, We.C.3436, We.C.3439,
We.C.3452, We.C.3454, We.C.3462,
We.C.3473, We.D.39 I1S

0
0
U
C
0l)
0
C~
0
G)
u
a)
L
500